LADENBURG THALMANN FINANCIAL SERVICES INC. - PACIRA PHARMACEUTICALS INC ownership

PACIRA PHARMACEUTICALS INC's ticker is PCRX and the CUSIP is 695127100. A total of 172 filers reported holding PACIRA PHARMACEUTICALS INC in Q1 2018. The put-call ratio across all filers is 2.09 and the average weighting 0.2%.

Quarter-by-quarter ownership
LADENBURG THALMANN FINANCIAL SERVICES INC. ownership history of PACIRA PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2019$89,000
+34.8%
1,968
+13.4%
0.00%
Q3 2019$66,000
-13.2%
1,735
-0.1%
0.00%
-100.0%
Q2 2019$76,000
+2.7%
1,736
-11.3%
0.00%0.0%
Q1 2019$74,000
-12.9%
1,957
-0.9%
0.00%0.0%
Q4 2018$85,000
-15.8%
1,974
-3.9%
0.00%0.0%
Q3 2018$101,000
+87.0%
2,055
+19.5%
0.00%0.0%
Q2 2018$54,0000.0%1,7190.0%0.00%0.0%
Q1 2018$54,000
-30.8%
1,7190.0%0.00%0.0%
Q4 2017$78,000
-20.4%
1,719
-34.2%
0.00%0.0%
Q3 2017$98,000
-50.0%
2,612
-36.3%
0.00%
-50.0%
Q2 2017$196,000
+3.2%
4,103
-2.1%
0.00%0.0%
Q1 2017$190,000
+187.9%
4,189
+111.9%
0.00%
+100.0%
Q4 2016$66,000
-1.5%
1,977
+2.3%
0.00%0.0%
Q3 2016$67,000
+28.8%
1,932
+24.0%
0.00%0.0%
Q2 2016$52,000
-66.0%
1,558
-46.1%
0.00%
-66.7%
Q1 2016$153,000
-42.0%
2,893
-15.6%
0.00%
-40.0%
Q4 2015$264,000
+142.2%
3,428
+28.6%
0.01%
+150.0%
Q3 2015$109,000
-39.4%
2,665
+4.6%
0.00%
-33.3%
Q2 2015$180,000
-19.6%
2,547
+0.9%
0.00%
-25.0%
Q1 2015$224,000
+47.4%
2,524
+46.7%
0.00%
+33.3%
Q4 2014$152,000
+1.3%
1,720
+11.0%
0.00%
-25.0%
Q3 2014$150,000
+12.8%
1,550
+6.9%
0.00%0.0%
Q2 2014$133,000
+31.7%
1,4500.0%0.00%
+33.3%
Q1 2014$101,000
+3266.7%
1,450
+2800.0%
0.00%
Q4 2013$3,000
+50.0%
500.0%0.00%
Q3 2013$2,000500.00%
Other shareholders
PACIRA PHARMACEUTICALS INC shareholders Q1 2018
NameSharesValueWeighting ↓
Gagnon Advisors, LLC 251,140$19,167,0008.83%
GAGNON SECURITIES LLC 610,933$46,626,0007.60%
Tamarack Advisers, LP 205,000$15,646,0007.40%
Spyglass Capital Management LLC 1,871,040$142,798,0004.88%
Lisanti Capital Growth, LLC 302,413$23,080,0002.59%
Rock Springs Capital Management LP 1,000,000$76,320,0001.92%
MESIROW FINANCIAL INVESTMENT MANAGEMENT - Fixed Income 208,197$15,890,0001.76%
JABODON PT CO 49,052$3,744,0001.70%
Zweig-DiMenna Associates LLC 166,675$12,721,0001.70%
NEUMEIER POMA INVESTMENT COUNSEL LLC 317,425$24,226,0001.63%
View complete list of PACIRA PHARMACEUTICALS INC shareholders